Keiko Ochiai

1.0k citations
35 papers · 687 indexed · h-index 17
Topics
Microbial Natural Products and Biosynthesis (10 papers)Cancer therapeutics and mechanisms (5 papers)Pediatric Hepatobiliary Diseases and Treatments (3 papers)
Partner nations
JapanSingaporeCanada

In The Last Decade

Keiko Ochiai

33 papers receiving 667 citations

Peers

Keiko Ochiai
Comparison fields: 5 of 90
  • Molecular Biology 393
  • Pharmacology 185
  • Organic Chemistry 137
  • Surgery 101
  • Biotechnology 83
Replace Peter P.K. Ho with:
Peter P.K. Ho United States
Morita Iwami Japan
KATSUO HATAYAMA Japan
Hayamitsu Adachi Japan
Chikara Shinohara Japan
Diana Kazanov Israel
Isao Uno Japan
Siegfried B. Christensen United States
Stanley J. Schmidt United States
Keiko Ochiai relative to Peter P.K. Ho United States Peter P.K. Ho's profile →
Citations per field
00.5×8.7×
Peter P.K. Ho · 1×
Citations per year

Countries citing papers authored by Keiko Ochiai

Since Specialization
Citations

This map shows the geographic impact of Keiko Ochiai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Ochiai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Ochiai more than expected).

Fields of papers citing papers by Keiko Ochiai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Ochiai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Ochiai. The network helps show where Keiko Ochiai may publish in the future.

Co-authorship network of co-authors of Keiko Ochiai

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Ochiai. A scholar is included among the top collaborators of Keiko Ochiai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Ochiai. Keiko Ochiai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 23
3 34
4 6
5 5
6 31
7 61
8
A Case of Patent Ductus Venosus
2
9 12
10 95
11 48
12 1
13
EI-1511-3, -5 and EI-1625-2, Novel Interleukin-1.BETA. Converting Enzyme Inhibitors Produced by Streptomyces sp. E-1511 and E-1625. I. Taxonomy of Producing Strain, Fermentation and Isolation.:I. Taxonomy of Producing Strain, Fermentation and Isolation
6
14 16
15 14
16 20
17 17
18 28
19 3
20 25

About Keiko Ochiai

Keiko Ochiai is a scholar working on Pharmacology, Filtration and Separation and Organic Chemistry, having authored 35 papers that have together received 687 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (10 papers), Cancer therapeutics and mechanisms (5 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). The work is most often cited by research in Biochemistry (82 citations), Pharmacology (185 citations) and Biotechnology (83 citations). Keiko Ochiai has collaborated with scholars based in Japan, Singapore and Canada. Frequent co-authors include Hajime Yoshida, Kazumi Araki, Hisami Ando, Yuzuru Matsuda, Mayumi Yoshida, Takashi Muramatsu, Hisako Muramatsu, Yutaka Saitoh, Katsuhiko Ando and Tamio Mizukami. Their work appears in journals such as Biochemical and Biophysical Research Communications, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026